CD8+ T cells divide cysteine between pathways that control growth and cancer-killing activity. Adjusting its use can enhance ...
Pressure on the heart as it pumps blood stops cancer cells from multiplying in mouse hearts. The beating of the heart stops ...
12don MSN
Multiple myeloma cells adapt after immunotherapy, helping explain why many patients relapse
Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...
A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...
Scientists may have discovered another way the human body tries to protect itself from cancer. New research on mice suggests ...
Skin cells can actively help the rabies virus multiply and pass into nearby nerve cells, explaining how even small bites or ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health have discovered how the ...
Researchers found that loss of HDAC7 disrupted B-cell maturation in mouse models. Restoring HDAC7 suppressed tumor growth, ...
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
Pancreatic cancer has stymied treatment advances for decades. Data from new clinical trials shows promise.
Researchers at the Josep Carreras Leukaemia Research Institute (IJC) discover that a single molecular switch, HDAC7, controls ...
A research team from the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns Hopkins Bloomberg School of Public Health have discovered how the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results